NicOx in-licenses ophthalmic diagnostics

NicOx SA, which has shifted its strategy to focus on ophthalmology, is to in-license point-of-care diagnostics from Rapid Pathogen Screening Inc. The agreement, financial terms of which were not disclosed, was announced on 21 June 2012.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

France